Showing results (1-10 of 276) with videos related to
Sort By:
Pageof 28
Hematology. American Society of Hematology. Education Program|December 9, 2022
Molecular prognostication in Ph-negative MPNs in 2022Alessandro Maria Vannucchi, Paola GuglielmelliCurrent Hematologic Malignancy Reports|October 4, 2015
What Do Molecular Tests Add to Prognostic Stratification in MF: Is It Time to Add These to Our Clinical Practice?Paola Guglielmelli, Giada Rotunno, Annalisa Pacilli, et al.Haematologica|February 14, 2007
B-, T-, and NK-cell lineage involvement in JAK2V617F-positive patients with idiopathic myelofibrosisCostanza Bogani, Paola Guglielmelli, Elisabetta Antonioli, et al.Hemoglobin|October 15, 2024
δβ-Thalassemia and α-Triplication: Is Genetic Retesting Worthwhile in Case of Non-Coherent Phenotype?Cristina Giubbilei, Simona D'Angelo, Ilaria Fotzi, et al.Stem Cells (Dayton, Ohio)|September 8, 2005
Differential amplification of murine bipotent megakaryocytic/erythroid progenitor and precursor cells during recovery from acute and chronic erythroid stressMassimo Sanchez, Irving L Weissman, Maria Pallavicini, et al.Blood Advances|April 23, 2021
Activated IL-6 signaling contributes to the pathogenesis of, and is a novel therapeutic target for, CALR-mutated MPNsManjola Balliu, Laura Calabresi, Niccolò Bartalucci, et al.JAMA|January 27, 2025
Essential Thrombocythemia: A ReviewAyalew Tefferi, Naseema Gangat, Giuseppe Gaetano Loscocco, et al.Experimental Hematology|March 2, 2023
Inhibition of CXCR1/2 reduces the emperipolesis between neutrophils and megakaryocytes in the Gata1low model of myelofibrosisFrancesca Arciprete, Paola Verachi, Fabrizio Martelli, et al.Journal of Hematology & Oncology|February 24, 2017
Driver mutations (JAK2V617F, MPLW515L/K or CALR), pentraxin-3 and C-reactive protein in essential thrombocythemia and polycythemia veraFederico Lussana, Alessandra Carobbio, Silvia Salmoiraghi, et al.International Journal of Molecular Sciences|January 19, 2017
Role of miR-34a-5p in Hematopoietic Progenitor Cells Proliferation and Fate Decision: Novel Insights into the Pathogenesis of Primary MyelofibrosisElisa Bianchi, Samantha Ruberti, Sebastiano Rontauroli, et al.Pageof 28